VisMederi Group is a research and qualified services company group operating in the field of Life Sciences and Public Health.
Joined July 2014
- Tweets 464
- Following 348
- Followers 295
- Likes 205
227 Photos and videos
Apr 20
Nel nuovo articolo su InsideOver del Prof. Emanuele Montomoli, “Lo spillover acquatico del virus marino Cmnv”, emerge uno scenario poco esplorato: il possibile passaggio all’uomo di un virus tipico degli ecosistemi acquatici.
it.insideover.com/geopolitic…
#Vismederigroup
28
Mar 17
A new article by Prof. Emanuele Montomoli on Insidover highlights a critical yet often overlooked aspect of global events: the health risks associated with mass gatherings.
it.insideover.com/geopolitic…
6
VisMederi is a partner in the EU-selected NOFLU consortium supporting early clinical development of a next-generation pandemic influenza vaccine
vismederiholding.com/vismede…
#VisMederiGroup
2
9
Feb 24
Brazil eliminates vertical HIV transmission as a public health problem: lessons from a successful prevention model.
lnkd.in/dhVf99GY
#GlobalHealth #PublicHealth #Prevention #HealthGeopolitics #Research #VisMederi #InsideOver #SalutePubblica #Prevenzione #Montomoli
1
18
3 Dec 2025
VisMederi America: a new chapter in the Group’s international growth
vismederiholding.com/vismede…
#VisMederi #VisMederiAmerica #VisMederigroup #Biotech #Vaccines #Research #USExpansion #LifeSciences #publichealth
1
1
18
VisMederi Group retweeted
13 Oct 2025
Thank you to our major supporters and sponsors: @CEPIvaccines, @TFGH, @AstraZeneca, @sanofi, @CSL, @pfizer and @VisMederi, whose contributions make #COP2025 possible
1
1
135
27 Nov 2025
Once again this year, VisMederi features in the “Leader of Growth 2026” ranking by Il Sole 24 Ore and Statista, among the Italian companies showing outstanding performance in terms of growth and development.
👉 Read the full news on our website: lnkd.in/dFwKh427
6
21 Nov 2025
The PEDVAC-iNTS project focuses on advancing the clinical development of a vaccine against non-typhoidal salmonellosis for infants in sub-Saharan Africa, addressing a neglected, poverty-related infectious disease
linkedin.com/feed/update/urn…
#VisMederi
10
3 Nov 2025
È uscito oggi su InsideOver un approfondimento firmato da Emanuele Montomoli dal titolo “La tecnologia a mRNA: come funziona il nuovo pilastro della medicina preventiva.”
it.insideover.com/geopolitic…
@E_Montomoli @insideoverita #VisMederigroup #MedicinaPreventiva #Innovazione
1
1
16
25 Aug 2025
Dalla morte nera medievale al colera dell’Ottocento, fino alle sfide di Covid-19, influenza e Monkeypox nel presente, i pellegrinaggi di massa sono stati spesso accompagnati dall’ombra del contagio.
it.insideover.com/geopolitic…
#VisMederi #Pandemie #geopolitica
2
18
20 Aug 2025
L'importanza della diagnostica nella lotta contro il cancro.
L'articolo a cura di Sara Pugliese su InsideOver
it.insideover.com/geopolitic…
@insideoverita #diagnostica #VisMederi
1
9
7 Apr 2025
Emanuele Montomoli (CSO & Founder) and Alessandro Manenti (CDO) are co-authors of a new scientific publication on a Phase II/III clinical study evaluating the immunogenicity, safety, and tolerability of a new SARS-CoV-2 booster vaccine
🔗 sciencedirect.com/science/ar…
1
1
129
27 Mar 2025
VisMederi represented at GVIRF 2025 by our CSO, Emanuele Montomoli. A valuable opportunity to be part of the global dialogue on vaccine research and innovation. 🌍
linkedin.com/posts/vismederi…
#VisMederi #GVIRF2025 #VaccineResearch #GlobalHealth
2
1
126
5 Feb 2025
Emanuele Montomoli, VisMederi's Chief Scientific Officer highlights the superior efficacy of the high-dose trivalent flu vaccination in protecting seniors from influenza.
👇
quotidianosanita.it/scienza-…
#VisMederi
1
1
38
23 Dec 2024
The VisMederi Group wishes you a very Merry Christmas and a prosperous New Year!
At VisMederi, public health is our commitment, and happiness is at the heart of everything we do. Thank you for being part of our journey.
#MerryChristmas #HappyNewYear #VisMederi
2
17
16 Sep 2024
At the 10th IBP BIOSAFETY CONFERENCE , our Unit Manager Adele Boccuto spoke on a crucial topic: "Emerging viral diseases in an era of global change."
As global challenges rise, so does the need for innovative solutions in biosafety.
#EmergingDiseases #Biosafety #VisMederi
27
11 Sep 2024
Prof. Emanuele Montomoli, Founder and CSO of VisMederi participated in the 52° Congresso SIM. He discussed "New Frontiers in Vaccinology", addressing recent advancements and their impact on public health. #Vaccinology #PublicHealth #Microbiology #SIM2024 #VisMederi
1
1
38
23 Aug 2024
VisMederi is prepared to support any research activity and overall vaccine development for the new public health emergency concerning monkeypox.
Read the full article here: pubmed.ncbi.nlm.nih.gov/3741…
#PublicHealth #Monkeypox #VaccineDevelopment #ResearchSupport #vismederi
5
5
243
7 Aug 2024
VisMederi has been successfully qualified by Qualifyze for conducting activities according to GCLP (Good Clinical Laboratory Practices).
Both our laboratory facilities have achieved the prestigious SILVER rating!
#VisMederi #Qualifyze #GCLP #SilverRating #LaboratoryExcellence
3
79
12 Jul 2024
Emanuele Montomoli (CSO and VisMederi Founder), Alessandro Manenti (CDO), and Silvia Grappi (Project Director) attended the CEPI Centralized Laboratory Network meeting in Rome.
#VisMederi #CEPI #Innovation #StandardizedAssays #FutureOutbreaks #HealthScience #RomeMeeting
2
4
403